Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONICpost hocanalysis

(2015) J.-F. Colombel et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Converging Goals of Treatment of Inflammatory Bowel Disease From Clinical Trials and Practice

(2015) Barrett G. Levesque et al.   GASTROENTEROLOGY

Crohn's disease management after intestinal resection: a randomised trial

(2015) Peter De Cruz et al.   LANCET

90 Comparison of the Impact of MRI and Colonoscopy on Management of Crohn's Disease

(2015) Orlando Garcia Bosch et al.   GASTROENTEROLOGY

Tu1106 Observer Agreement and Construct Validity in Central Endoscopic Assessment of Disease Activity in Ulcerative Colitis

(2015) Suresh Pola et al.   GASTROENTEROLOGY

A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity

(2014) R. Khanna et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Fatigue is highly associated with poor health-related quality of life, disability and depression in newly-diagnosed patients with inflammatory bowel disease, independent of disease activity

(2014) B. L. Cohen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptom Scales

(2014) Brennan M R Spiegel et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy

(2014) Marianne K Vester-Andersen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis

(2014) Mark T. Osterman et al.   Clinical Gastroenterology and Hepatology

Patient-Reported Outcomes as Primary End Points in Clinical Trials of Inflammatory Bowel Disease

(2014) Nicolas Williet et al.   Clinical Gastroenterology and Hepatology

Biomarkers of Inflammatory Bowel Disease

(2014) Yi Fengming et al.   DISEASE MARKERS

Sa1198 Agreement Among Experts in the Endoscopic Evaluation of Postoperative Recurrence in Crohn's Disease Using the Rutgeerts Score

(2014) Krisztina Gecse et al.   GASTROENTEROLOGY

Comparison of Magnetic Resonance and Balloon Enteroscopic Examination of the Small Intestine in Patients With Crohn's Disease

(2014) Kento Takenaka et al.   GASTROENTEROLOGY

Histologic Evaluation of Ulcerative Colitis

(2014) Mahmoud H. Mosli et al.   INFLAMMATORY BOWEL DISEASES

Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease — An ECCO-EpiCom study☆

(2014) J. Burisch et al.   Journal of Crohns & Colitis

P150 Responsiveness of endoscopic indices in the evaluation of ulcerative colitis

(2014) B.G. Levesque et al.   Journal of Crohns & Colitis

Systematic review: Histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative

(2014) R.V. Bryant et al.   Journal of Crohns & Colitis

IBD and health-related quality of life — Discovering the true impact

(2014) Sanna Lönnfors et al.   Journal of Crohns & Colitis

Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases

(2014) William J. Sandborn et al.   Journal of Crohns & Colitis

Multilayered epithelium at the gastroesophageal junction is a marker of gastroesophageal reflux disease: data from a prospective Central European multicenter study (histoGERD trial)

(2014) Cord Langner et al.   VIRCHOWS ARCHIV

Review article: description and management of fatigue in inflammatory bowel disease

(2013) W. Czuber-Dochan et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE

(2013) R. Panaccione et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Changes in Fatigue Over 2 Years Are Associated With Activity of Inflammatory Bowel Disease and Psychological Factors

(2013) Lesley A. Graff et al.   Clinical Gastroenterology and Hepatology

Adalimumab Induces Deep Remission in Patients With Crohn's Disease

(2013) Jean–Frédéric Colombel et al.   Clinical Gastroenterology and Hepatology

Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?

(2013) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Low Prevalence of Disability Among Patients With Inflammatory Bowel Diseases a Decade After Diagnosis

(2013) Eran Israeli et al.   Clinical Gastroenterology and Hepatology

Correlations of C-reactive Protein Levels and Erythrocyte Sedimentation Rates with Endoscopic Activity Indices in Patients with Ulcerative Colitis

(2013) Jin Young Yoon et al.   DIGESTIVE DISEASES AND SCIENCES

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

(2013) Marc Ferrante et al.   GASTROENTEROLOGY

Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

(2013) Simon P.L. Travis et al.   GASTROENTEROLOGY

Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies

(2013) Alexandra D. Frolkis et al.   GASTROENTEROLOGY

The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcerative Colitis

(2013) Brian G. Feagan et al.   GASTROENTEROLOGY

Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease

(2013) Ingrid Ordás et al.   GASTROENTEROLOGY

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

(2013) Remo Panaccione et al.   GASTROENTEROLOGY

Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis

(2013) William J. Sandborn et al.   GASTROENTEROLOGY

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

(2013) Laurent Peyrin-Biroulet et al.   GUT

Syndecan-1 and Heparanase

(2013) Shaoheng Zhang et al.   INFLAMMATORY BOWEL DISEASES

Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy

(2013) Martine De Vos et al.   INFLAMMATORY BOWEL DISEASES

Factors Associated with Physical and Cognitive Fatigue in Patients With Crohnʼs Disease

(2013) Daniel R. van Langenberg et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy

(2013) Takayuki Yamamoto et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

P215 Endoscopic remission (Mayo score 0 rather than score 1) predicts long-term clinical remission in ulcerative colitis

(2013) N. Inoue et al.   Journal of Crohns & Colitis

European consensus on the histopathology of inflammatory bowel disease

(2013) F. Magro et al.   Journal of Crohns & Colitis

Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines

(2013) J. Panes et al.   Journal of Crohns & Colitis

European evidence based consensus for endoscopy in inflammatory bowel disease

(2013) Vito Annese et al.   Journal of Crohns & Colitis

Determinants of health-related quality of life in Crohn's disease: A systematic review and meta-analysis

(2013) Mike van der Have et al.   Journal of Crohns & Colitis

Risk factors of work disability in patients with inflammatory bowel disease — A Dutch nationwide web-based survey

(2013) Mirthe E. van der Valk et al.   Journal of Crohns & Colitis

Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy

(2013) Michael Sherman et al.   Journal of Digestive Diseases

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2013) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis

(2013) Kaoru Yokoyama et al.   Gastroenterology Research and Practice

How Fatigue Is Experienced and Handled by Female Outpatients with Inflammatory Bowel Disease

(2013) Anne Beck et al.   Gastroenterology Research and Practice

C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I

(2012) W. Reinisch et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2

(2012) W. J. Sandborn et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion Process

(2012) Laurent Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Validation of the Ulcerative Colitis Colonoscopic Index of Severity and Its Correlation With Disease Activity Measures

(2012) Sunil Samuel et al.   Clinical Gastroenterology and Hepatology

Determinants of fatigue in Crohn’s disease patients

(2012) Lauran Vogelaar et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Decreasing Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease Over 30 Years

(2012) Tine Jess et al.   GASTROENTEROLOGY

Hospitalisations and surgery in Crohn's disease

(2012) Charles N Bernstein et al.   GUT

Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study

(2012) Ingrid Ordás et al.   GUT

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

(2012) Marte Lie Høivik et al.   GUT

Mucosal healing in inflammatory bowel diseases: a systematic review

(2012) Markus F Neurath et al.   GUT

Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

(2012) Pauliina Molander et al.   INFLAMMATORY BOWEL DISEASES

Risk factors of anxiety and depression in inflammatory bowel disease

(2012) Stéphane Nahon et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

Mucosal Healing in Crohnʼs Disease

(2012) Peter De Cruz et al.   INFLAMMATORY BOWEL DISEASES

Chronic fatigue is associated with increased disease-related worries and concerns in inflammatory bowel disease

(2012) Lars-Petter Jelsness-Jørgensen   WORLD JOURNAL OF GASTROENTEROLOGY

Validation of the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) in patients with inflammatory bowel disease

(2011) A. Tinsley et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease

(2011) J. Panés et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Increased Risks of Developing Anxiety and Depression in Young Patients With Crohn's Disease

(2011) Edward V Loftus et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Computed Tomography Enterography Detects Intestinal Wall Changes and Effects of Treatment in Patients With Crohn's Disease

(2011) David H. Bruining et al.   Clinical Gastroenterology and Hepatology

Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease

(2011) Matthias Jürgens et al.   Clinical Gastroenterology and Hepatology

Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease: A Randomized Placebo-Controlled Trial

(2011) Jill P. Smith et al.   DIGESTIVE DISEASES AND SCIENCES

The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease

(2011) James D. Lewis   GASTROENTEROLOGY

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

(2011) Jean Frédéric Colombel et al.   GASTROENTEROLOGY

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

(2011) Edouard Louis et al.   GASTROENTEROLOGY

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

(2011) William J. Sandborn et al.   GASTROENTEROLOGY

Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health

(2011) Laurent Peyrin-Biroulet et al.   GUT

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

(2011) Simon P L Travis et al.   GUT

Benefit of Computed Tomography Enterography in Crohnʼs Disease: Effects on Patient Management and Physician Level of Confidence§†

(2011) David H. Bruining et al.   INFLAMMATORY BOWEL DISEASES

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohnʼs disease: A marker for patient classification?

(2011) Lajos Sandor Kiss et al.   INFLAMMATORY BOWEL DISEASES

Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence

(2011) Joana Torres et al.   INFLAMMATORY BOWEL DISEASES

Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts

(2011) Fernando Magro et al.   INFLAMMATORY BOWEL DISEASES

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity

(2010) Severine Vermeire et al.   Clinical Gastroenterology and Hepatology

Severe Pediatric Ulcerative Colitis: A Prospective Multicenter Study of Outcomes and Predictors of Response

(2010) Dan Turner et al.   GASTROENTEROLOGY

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

(2010) W. Reinisch et al.   GUT

Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease

(2010) A. Oussalah et al.   GUT

Fatigue and health-related quality of life in inflammatory bowel disease

(2010) M. J.L. Romberg-Camps et al.   INFLAMMATORY BOWEL DISEASES

Measurement of disease activity in ulcerative colitis

(2010) Kelvin T. Thia et al.   INFLAMMATORY BOWEL DISEASES

Development of the Crohnʼs disease digestive damage score, the Lémann score

(2010) Benjamin Pariente et al.   INFLAMMATORY BOWEL DISEASES

Magnetic resonance imaging for evaluation of Crohnʼs disease

(2010) Jordi Rimola et al.   INFLAMMATORY BOWEL DISEASES

Long-term complications, extraintestinal manifestations, and mortality in adult Crohnʼs disease in population-based cohorts

(2010) Laurent Peyrin-Biroulet et al.   INFLAMMATORY BOWEL DISEASES

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Natural History of Adult Crohn's Disease in Population-Based Cohorts

(2009) Laurent Peyrin-Biroulet et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prospective Comparison of State-of-the-Art MR Enterography and CT Enterography in Small-Bowel Crohn's Disease

(2009) Hassan A. Siddiki et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

A Systematic Prospective Comparison of Noninvasive Disease Activity Indices in Ulcerative Colitis

(2009) Dan Turner et al.   Clinical Gastroenterology and Hepatology

Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

(2009) Filip Baert et al.   GASTROENTEROLOGY

Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease

(2009) J. Rimola et al.   GUT

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

(2009) Javier P. Gisbert et al.   INFLAMMATORY BOWEL DISEASES

Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management

(2009) Lesley A. Graff et al.   INFLAMMATORY BOWEL DISEASES

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease

(2009) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

Defining the Optimal Response Criteria for the Crohn's Disease Activity Index for Induction Studies in Patients With Mildly to Moderately Active Crohn's Disease

(2008) Kelvin T. Thia et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effects of Adalimumab Maintenance Therapy on Health-Related Quality of Life of Patients With Crohn's Disease: Patient-Reported Outcomes of the CHARM Trial

(2008) Edward V. Loftus et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis

(2008) Wulfran Cacheux et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The Clinical Utility of High-Sensitivity C-Reactive Protein in Cardiovascular Disease and the Potential Implication of JUPITER on Current Practice Guidelines

(2008) S. Mora et al.   CLINICAL CHEMISTRY

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease

(2008) Jennifer Jones et al.   Clinical Gastroenterology and Hepatology

Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse

(2008) Xavier Treton et al.   Clinical Gastroenterology and Hepatology

Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease

(2008) Margaret C. Reilly et al.   CLINICAL THERAPEUTICS

Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial

(2008) James D. Lewis et al.   GASTROENTEROLOGY

Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial

(2008) Craig A. Solem et al.   GASTROINTESTINAL ENDOSCOPY

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

(2008) M Henriksen et al.   GUT

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease

(2008) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis

(2008) Taro Osada et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Steroid-refractory ulcerative colitis: Predictive factors of response to cyclosporine and validation in an independent cohort

(2007) Montserrat Aceituno et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES